| abstract |
The invention relates to a binding molecule, which has at least bispecificity and includes a first binding domain and a second binding domain, wherein the first binding domain can bind to the third epitope of BCMA and the second binding domain Domains can bind to T-cell CD3 receptor complexes. In addition, the present invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising the nucleic acid sequence, and a host cell transformed or transfected with the vector. Furthermore, the present invention provides a method for producing a binding molecule of the present invention, a medical use of the binding molecule, and a set comprising the binding molecule. |